MA-PEG4-VC-PAB-DMEA-Doxorubicin
MA-PEG4-VC-PAB-DMEA-Doxorubicin is a thiol-reactive linker-payload construct designed for antibody-drug conjugate (ADC) synthesis. It enables targeted delivery of the cytotoxic agent doxorubicin, facilitating research into ADC efficacy and mechanism in both in vitro and in vivo cancer models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog